Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
Proton pump inhibitors (omeprazole, esomeprazole)
NDH at 42-47 mmol/mol or 6.0-6.4%), fasting plasma glucose (diabetes 7.0 mmol/L), lipid profiles, and thyroid function tests as clinically indicated
Related Stories AI reveals effective combination therapy for advanced rectal cancer Experimental therapy helps brain cells bypass genetic deletions Discovery of calcium channel mechanism offers clues for brain disorder treatments Major challenges in microsphere and microparticle systems include complex, costly manufacturing processes, product variability, and environmental degradation of certain components
It has been approved as a second line treatment option for better glycaemic control in type 2 diabetes and currently under scrutiny for anti-obesity purpose
It was found that administration of di(2-ethylhexyl)phthalate (DEHP), a peroxisomal proliferator, to Wistar rats led to an increase in the expression of CROT by a factor of 14.1
US$ 26.56
US$ 29.39
US$ 28.51
US$ 29.00
